Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cyclo Therapeutics Inc (NQ: CYTH )

0.7100 +0.0100 (+1.43%)
Streaming Delayed Price Updated: 9:48 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cyclo Therapeutics Inc

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Cyclo Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Achievements
From Cyclo Therapeutics
Via Business Wire
Cyclo Therapeutics Announces Publication of Phase 1 Data for Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C1 (NPC1)
From Cyclo Therapeutics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Friday
On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... 
Via Benzinga
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
Gainers Starry Group Holdings, Inc. (NYSE: STRY) rose 55.6% to close at $0.28 on Wednesday after reporting Q3 results. 
Via Benzinga
Cyclo Therapeutics Commences Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics Provides Business Update
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics, TRACON Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones dropped by more than 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
Cyclo Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
From Cyclo Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
  
Via Benzinga
Cyclo Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics to Present at the China NPC Association Meeting
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics to Present at the NNPDF-INPDA Conferences 2022
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics to Present at the World Orphan Drug Congress USA 2022
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics to Present at the 2022 NPC Patient and Family Conference Hosted by the Australian NPC Disease Foundation
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics to Participate in the H.C. Wainwright Global Investment Conference
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics Provides Business Update and Reports First Quarter 2022 Financial Results
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics to Participate in the Virtual Investor Niemann-Pick Disease Type C Spotlight Event
From Cyclo Therapeutics, Inc.
Via Business Wire
Follow the Insiders and Buy the Dip in These 3 Stocks
These three biotech companies have all had insiders buying shares recently. That's a good sign for the future of their treatments. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
4 Penny Stocks Insiders Are Buying
US crude oil futures traded sharply lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
Cyclo Therapeutics to Participate in the Virtual Investor Alzheimer’s Disease Spotlight Event
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics Enters Research and Collaboration Agreement with Wits Commercial Enterprise (Pty) Ltd to Explore Potential Applications of Trappsol® Cyclo™ to Expand Pipeline
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q4, Cyclo Therapeutics's (NASDAQ:CYTH) reported sales totaled $585.12 thousand. Despite a 27.66% increase in earnings, the company... 
Via Benzinga
Cyclo Therapeutics Provides Business Update and Reports Full Year 2021 Financial Results
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics Selected to Present Overview of Pivotal Phase 3 Study for Lead Candidate, Trappsol® Cyclo™, at WORLDSymposium 2022
From Cyclo Therapeutics, Inc.
Via Business Wire
Executives Buy Over $6M Of 5 Penny Stocks
Although gold prices traded slightly lower to below $1,820 an ounce on Tuesday ahead of US inflation data due later in the week, there were a few notable insider trades. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.